(PubMed) Hershman DL, Unger JM, Crew KD, et al
Evidence-based positioning of sodium-glucose co-transporter protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in the management of chronic kidney disease with type 2 diabetes and overweight or obesity: a systematic literature review
10.1111/j.1346-8138.2008.00511.x 50 ColucciR.DragoniF.MorettiS
The most common AEs recorded following administration of PF-06882961 were nausea, vomiting, and decreased appetite, all of which were considered treatment-related by the investigator and consistent with the expected effects of the GLP-1R agonist mechanism
kim duyt Cc bi vit lin quan Du m u c xem l thn dc trong vic lm lnh v ti to da, c bit l kh nng tr so c nhiu ngi truyn tai nhau p dng
It can slow down how fast you get drunk, giving you a bit more time, as well as decreasing the hungover feeling the next day